Chem Shift validation: AVS_full, LACS
BMRB Entry DOI: doi:10.13018/BMR27520
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Padua, Ricardo; Sun, Yizhi; Marko, Ingrid; Pitsawong, Warintra; Stiller, John; Otten, Renee; Kern, Dorothee. "Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2" Nat. Commun. 9, 4507-4507 (2018).
PubMed: 30375376
Assembly members:
shp2-fl-deltaC, polymer, 532 residues, 60930.8584 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pET28a(+)
Data type | Count |
13C chemical shifts | 934 |
15N chemical shifts | 316 |
1H chemical shifts | 316 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | shp2-fl-deltaC | 1 |
Entity 1, shp2-fl-deltaC 532 residues - 60930.8584 Da.
Residue 1-3 represent a non-native sequence to facilitate TEV cleavage.
1 | GLY | SER | GLY | MET | THR | SER | ARG | ARG | TRP | PHE | ||||
2 | HIS | PRO | ASN | ILE | THR | GLY | VAL | GLU | ALA | GLU | ||||
3 | ASN | LEU | LEU | LEU | THR | ARG | GLY | VAL | ASP | GLY | ||||
4 | SER | PHE | LEU | ALA | ARG | PRO | SER | LYS | SER | ASN | ||||
5 | PRO | GLY | ASP | PHE | THR | LEU | SER | VAL | ARG | ARG | ||||
6 | ASN | GLY | ALA | VAL | THR | HIS | ILE | LYS | ILE | GLN | ||||
7 | ASN | THR | GLY | ASP | TYR | TYR | ASP | LEU | TYR | GLY | ||||
8 | GLY | GLU | LYS | PHE | ALA | THR | LEU | ALA | GLU | LEU | ||||
9 | VAL | GLN | TYR | TYR | MET | GLU | HIS | HIS | GLY | GLN | ||||
10 | LEU | LYS | GLU | LYS | ASN | GLY | ASP | VAL | ILE | GLU | ||||
11 | LEU | LYS | TYR | PRO | LEU | ASN | CYS | ALA | ASP | PRO | ||||
12 | THR | SER | GLU | ARG | TRP | PHE | HIS | GLY | HIS | LEU | ||||
13 | SER | GLY | LYS | GLU | ALA | GLU | LYS | LEU | LEU | THR | ||||
14 | GLU | LYS | GLY | LYS | HIS | GLY | SER | PHE | LEU | VAL | ||||
15 | ARG | GLU | SER | GLN | SER | HIS | PRO | GLY | ASP | PHE | ||||
16 | VAL | LEU | SER | VAL | ARG | THR | GLY | ASP | ASP | LYS | ||||
17 | GLY | GLU | SER | ASN | ASP | GLY | LYS | SER | LYS | VAL | ||||
18 | THR | HIS | VAL | MET | ILE | ARG | CYS | GLN | GLU | LEU | ||||
19 | LYS | TYR | ASP | VAL | GLY | GLY | GLY | GLU | ARG | PHE | ||||
20 | ASP | SER | LEU | THR | ASP | LEU | VAL | GLU | HIS | TYR | ||||
21 | LYS | LYS | ASN | PRO | MET | VAL | GLU | THR | LEU | GLY | ||||
22 | THR | VAL | LEU | GLN | LEU | LYS | GLN | PRO | LEU | ASN | ||||
23 | THR | THR | ARG | ILE | ASN | ALA | ALA | GLU | ILE | GLU | ||||
24 | SER | ARG | VAL | ARG | GLU | LEU | SER | LYS | LEU | ALA | ||||
25 | GLU | THR | THR | ASP | LYS | VAL | LYS | GLN | GLY | PHE | ||||
26 | TRP | GLU | GLU | PHE | GLU | THR | LEU | GLN | GLN | GLN | ||||
27 | GLU | CYS | LYS | LEU | LEU | TYR | SER | ARG | LYS | GLU | ||||
28 | GLY | GLN | ARG | GLN | GLU | ASN | LYS | ASN | LYS | ASN | ||||
29 | ARG | TYR | LYS | ASN | ILE | LEU | PRO | PHE | ASP | HIS | ||||
30 | THR | ARG | VAL | VAL | LEU | HIS | ASP | GLY | ASP | PRO | ||||
31 | ASN | GLU | PRO | VAL | SER | ASP | TYR | ILE | ASN | ALA | ||||
32 | ASN | ILE | ILE | MET | PRO | GLU | PHE | GLU | THR | LYS | ||||
33 | CYS | ASN | ASN | SER | LYS | PRO | LYS | LYS | SER | TYR | ||||
34 | ILE | ALA | THR | GLN | GLY | CYS | LEU | GLN | ASN | THR | ||||
35 | VAL | ASN | ASP | PHE | TRP | ARG | MET | VAL | PHE | GLN | ||||
36 | GLU | ASN | SER | ARG | VAL | ILE | VAL | MET | THR | THR | ||||
37 | LYS | GLU | VAL | GLU | ARG | GLY | LYS | SER | LYS | CYS | ||||
38 | VAL | LYS | TYR | TRP | PRO | ASP | GLU | TYR | ALA | LEU | ||||
39 | LYS | GLU | TYR | GLY | VAL | MET | ARG | VAL | ARG | ASN | ||||
40 | VAL | LYS | GLU | SER | ALA | ALA | HIS | ASP | TYR | THR | ||||
41 | LEU | ARG | GLU | LEU | LYS | LEU | SER | LYS | VAL | GLY | ||||
42 | GLN | GLY | ASN | THR | GLU | ARG | THR | VAL | TRP | GLN | ||||
43 | TYR | HIS | PHE | ARG | THR | TRP | PRO | ASP | HIS | GLY | ||||
44 | VAL | PRO | SER | ASP | PRO | GLY | GLY | VAL | LEU | ASP | ||||
45 | PHE | LEU | GLU | GLU | VAL | HIS | HIS | LYS | GLN | GLU | ||||
46 | SER | ILE | MET | ASP | ALA | GLY | PRO | VAL | VAL | VAL | ||||
47 | HIS | CYS | SER | ALA | GLY | ILE | GLY | ARG | THR | GLY | ||||
48 | THR | PHE | ILE | VAL | ILE | ASP | ILE | LEU | ILE | ASP | ||||
49 | ILE | ILE | ARG | GLU | LYS | GLY | VAL | ASP | CYS | ASP | ||||
50 | ILE | ASP | VAL | PRO | LYS | THR | ILE | GLN | MET | VAL | ||||
51 | ARG | SER | GLN | ARG | SER | GLY | MET | VAL | GLN | THR | ||||
52 | GLU | ALA | GLN | TYR | ARG | PHE | ILE | TYR | MET | ALA | ||||
53 | VAL | GLN | HIS | TYR | ILE | GLU | THR | LEU | GLN | ARG | ||||
54 | ARG | ILE |
shp2-fl_fully-deuterated: shp2-fl-deltaC, [U-13C; U-15N; U-2H], 0.2 mM; ADA 50 mM; TCEP 2 mM; H2O 90%; D2O 10%
shp2-fl_partially-deuterated: shp2-fl-deltaC, [U-13C; U-15N; U-2H], 0.2 mM; ADA 50 mM; TCEP 2 mM; H2O 90%; D2O 10%
Default: ionic strength: 0.100 M; pH: 6.500; pressure: 1.000 atm; temperature: 308.000 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
3D HNCO | shp2-fl_partially-deuterated | isotropic | Default |
3D HNCA | shp2-fl_partially-deuterated | isotropic | Default |
2D 1H-15N HSQC/HMQC | shp2-fl_fully-deuterated | isotropic | Default |
3D HNCACB | shp2-fl_fully-deuterated | isotropic | Default |
CcpNmr_Analysis v2.4, CCPN - Spetrum analysis, Spetrum display
nmrPipe vany, Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax - Spectrum processing
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks